滕士超利湿化瘀通络治疗糖尿病肾病微量蛋白尿  

Professor Teng Shichao’s Experience in Treating Diabetic Nephropathy with Microalbuminuria

作　　者：姜婷 安晓飞[1] 王慧[1] 滕士超[1] JIANG Ting;AN Xiaofei;WANG Hui;TENG Shichao(Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210029,Jiangsu,China)

机构地区：[1]南京中医药大学附属医院,江苏南京210029

出　　处：《实用中医内科杂志》2022年第7期80-82,共3页Journal of Practical Traditional Chinese Internal Medicine

基　　金：江苏省中医药局科技项目(YB2017012)。

摘　　要：糖尿病肾病(DN)是糖尿病最常见的慢性微血管并发症之一,是造成终末期肾脏病的主要原因。蛋白尿的程度与该病的严重程度呈正相关,针对蛋白尿的治疗尤为重要。在糖尿病肾病早期,微量蛋白尿是其主要特征。滕士超教授从“湿瘀阻络”的基本病机出发,拟定具有“利湿化瘀通络”功效的消肾方,灵活加减,能延缓DN的进展,疗效显著。Diabetic nephropathy(DN)is one of the most common chronic microvascular complications of diabetes and is the leading cause of end-stage renal disease.The degree of proteinuria is positively correlated with the severity of the disease,so the treatment for proteinuria is particularly important.In the early stages of diabetic nephropathy,microalbuminuria is its main feature.Professor Teng Shichao has considerable experience in the treatment of microalbuminuria in the early stage of DN.Based on the basic principle of"dampness and blood stasis blocking collaterals"in traditional Chinese medicine,Xiaoshen Fang with the effect of"dampness and dredging collaterals"and with flexible addition and subtraction,multiple successfully treated of DN early proteinuria,and delay the progression of DN.

关 键 词：糖尿病肾病 湿瘀阻络 蛋白尿 滕士超 

分 类 号：R587.2[医药卫生—内分泌]